Lithium is unlikely to cause meaningful liver damage. Unlike many psychiatric medications, lithium is not processed by the liver at all. It enters the body, circulates unchanged, and is excreted entirely through the kidneys. The NIH’s LiverTox database gives lithium a likelihood score of E, meaning it is an “unlikely cause of clinically apparent liver injury.” No cases of acute liver failure or chronic liver disease have been attributed to lithium.
Why Lithium Largely Bypasses the Liver
Most medications are broken down (metabolized) by liver enzymes before the body can eliminate them. This process is what creates the potential for liver stress or damage with many drugs. Lithium is different. It undergoes no metabolic transformation in humans and leaves the body in its original form through urine. Because the liver doesn’t have to process it, the drug places very little biochemical demand on liver tissue.
Minor Liver Enzyme Changes on Routine Blood Work
A small proportion of people on long-term lithium therapy do show mild elevations in liver enzymes (aminotransferases, the markers commonly tested in a liver panel). If you see a slight bump on your blood work, that alone is not a sign of liver injury. These elevations are typically asymptomatic, transient, and tend to resolve on their own, even if you keep taking lithium at the same dose. They generally do not require a dose change or stopping the medication.
Lithium has never been convincingly linked to clinically apparent acute liver injury, and no cases of jaundice caused by lithium have been documented. In practical terms, a mildly elevated liver enzyme reading while taking lithium is far more likely to have another explanation, such as alcohol use, another medication, or a viral illness.
Lithium Overdose and the Liver
In overdose situations, more noticeable liver enzyme elevations have been reported. However, even in these cases, the liver effects are not the primary concern. Lithium toxicity overwhelmingly affects the kidneys, nervous system, and heart. The liver changes seen during overdose are a minor footnote compared to the more serious systemic problems, and they do not progress to liver failure.
Using Lithium With Existing Liver Disease
Because lithium skips liver metabolism entirely, it is generally considered safe for people with pre-existing liver conditions, including chronic liver disease. In fact, this is one of lithium’s advantages over other mood stabilizers. Medications like valproate are heavily processed by the liver and carry well-documented risks of liver toxicity, making them poor choices for patients with hepatic impairment. Lithium sidesteps that concern.
That said, liver disease introduces an indirect complication. People with cirrhosis often have reduced kidney function at the same time, and because lithium is eliminated entirely through the kidneys, impaired kidney function makes it harder to keep lithium at a safe, effective blood level. The therapeutic window for lithium is narrow: too little doesn’t work, and too much becomes toxic. Cirrhosis also makes standard kidney function tests less reliable, because the liver produces less of a substance (creatine) that those tests measure. This means kidney performance can look better on paper than it actually is.
For anyone with liver disease taking lithium, more frequent blood level monitoring is the key safeguard. The concern is kidney clearance, not direct liver harm.
How Lithium Compares to Other Mood Stabilizers
If you’re weighing lithium against alternatives and liver safety is a factor, lithium has a clear advantage. Valproate (sold under brand names like Depakote) is one of the most commonly prescribed mood stabilizers, and it carries a meaningful risk of liver damage, including rare cases of fatal liver failure. Carbamazepine, another option, is also metabolized by the liver and can cause hepatotoxicity. Lithium’s renal elimination pathway means it avoids this category of risk almost entirely.
The trade-off is that lithium’s primary organ of concern is the kidney, not the liver. Long-term use can affect kidney function over time, and regular monitoring of kidney health is a standard part of lithium therapy. If your worry is specifically about the liver, lithium is one of the gentler options available in psychiatric medicine.